Sangamo Therapeutics
SGMO
#10563
Rank
A$42.8 M
Marketcap
A$0.10
Share price
0.00%
Change (1 day)
-87.48%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -A$0.17 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$34.55 Million. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.17 Billion9%
2025 -A$0.16 Billion9.71%
2024 -A$0.14 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.26 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.11 Billion36.89%
2017 -A$78.69 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$65.42 Million75.62%
2014 -A$37.25 Million0.13%
2013 -A$37.21 Million
2011 -A$50.01 Million43.66%
2010 -A$34.82 Million28.52%
2009 -A$27.09 Million-23.55%
2008 -A$35.44 Million2.45%
2007 -A$34.59 Million19.5%
2006 -A$28.94 Million50.78%
2005 -A$19.2 Million75%
2004 -A$10.97 Million-33.25%
2003 -A$16.44 Million-62.27%
2002 -A$43.55 Million102.82%
2001 -A$21.48 Million23.21%
2000 -A$17.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.68 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.26 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.53 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.97 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.36 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.21 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.53 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA